203 related articles for article (PubMed ID: 37871842)
21. Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B.
Mak LY; Hui RW; Fung J; Liu F; Wong DK; Cheung KS; Yuen MF; Seto WK
J Hepatol; 2020 Oct; 73(4):800-806. PubMed ID: 32504663
[TBL] [Abstract][Full Text] [Related]
22. Artificial neural network accurately predicts hepatitis B surface antigen seroclearance.
Zheng MH; Seto WK; Shi KQ; Wong DK; Fung J; Hung IF; Fong DY; Yuen JC; Tong T; Lai CL; Yuen MF
PLoS One; 2014; 9(6):e99422. PubMed ID: 24914537
[TBL] [Abstract][Full Text] [Related]
23. A predictive scoring system for the seroclearance of HBsAg in HBeAg-seronegative chronic hepatitis B patients with genotype B or C infection.
Liu J; Lee MH; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; Wang LY; You SL; Hsiao CK; Yang HI; Chen CJ
J Hepatol; 2013 May; 58(5):853-60. PubMed ID: 23246508
[TBL] [Abstract][Full Text] [Related]
24. Deep sequencing shows that HBV basal core promoter and precore variants reduce the likelihood of HBsAg loss following tenofovir disoproxil fumarate therapy in HBeAg-positive chronic hepatitis B.
Bayliss J; Yuen L; Rosenberg G; Wong D; Littlejohn M; Jackson K; Gaggar A; Kitrinos KM; Subramanian GM; Marcellin P; Buti M; Janssen HLA; Gane E; Sozzi V; Colledge D; Hammond R; Edwards R; Locarnini S; Thompson A; Revill PA
Gut; 2017 Nov; 66(11):2013-2023. PubMed ID: 27534671
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
26. Circulating microRNA-122 levels are important predictor of hepatitis B virus surface antigen seroclearance.
Akuta N; Suzuki F; Kobayashi M; Hosaka T; Fujiyama S; Kawamura Y; Sezaki H; Kobayashi M; Saitoh S; Suzuki Y; Arase Y; Ikeda K; Kumada H
J Med Virol; 2018 Oct; 90(10):1586-1592. PubMed ID: 29896794
[TBL] [Abstract][Full Text] [Related]
27. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients.
Yeo YH; Tseng TC; Hosaka T; Cunningham C; Fung JYY; Ho HJ; Kwak MS; Trinh HN; Ungtrakul T; Yu ML; Kobayashi M; Le AK; Henry L; Li J; Zhang J; Sriprayoon T; Jeong D; Tanwandee T; Gane E; Cheung RC; Wu CY; Lok AS; Lee HS; Suzuki F; Yuen MF; Kao JH; Yang HI; Nguyen MH
Clin Transl Gastroenterol; 2020 Sep; 11(9):e00196. PubMed ID: 33094953
[TBL] [Abstract][Full Text] [Related]
28. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B.
Zhang M; Li J; Xu Z; Fan P; Dong Y; Wang F; Gao Y; Yan J; Cao L; Ji D; Feng D; Zhong Y; Zhang Y; Hong W; Zhang C; Wang FS
Hepatol Int; 2024 Apr; 18(2):435-448. PubMed ID: 38376650
[TBL] [Abstract][Full Text] [Related]
29. Cumulative incidence of hepatocellular carcinoma and hepatitis B surface antigen Seroclearance after Nucleos(t) ide analogue-induced hepatitis B e antigen Seroclearance.
Lee HW; Lee JI; Kim S; Kim S; Chang HY; Lee KS
BMC Gastroenterol; 2020 Apr; 20(1):113. PubMed ID: 32305059
[TBL] [Abstract][Full Text] [Related]
30. Single-nucleotide polymorphism of rs7944135 (macrophage-expressed gene 1) is associated with hepatitis B surface antigen seroclearance in chronic hepatitis B infection: A cohort study.
Irham LM; Wong HS; Perwitasari DA; Chou WH; Yang HI; Chang WC
Medicine (Baltimore); 2019 Dec; 98(51):e17936. PubMed ID: 31860948
[TBL] [Abstract][Full Text] [Related]
31. Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B.
Jeng WJ; Chen YC; Chien RN; Sheen IS; Liaw YF
Hepatology; 2018 Aug; 68(2):425-434. PubMed ID: 29108132
[TBL] [Abstract][Full Text] [Related]
32. When can we stop nucleoside analogues in patients with chronic hepatitis B?
Chong CH; Lim SG
Liver Int; 2017 Jan; 37 Suppl 1():52-58. PubMed ID: 28052620
[TBL] [Abstract][Full Text] [Related]
33. Early Hepatitis B Surface Antigen Seroclearance Following Antiviral Treatment in Patients with Reactivation of Resolved Hepatitis B.
Lee HL; Jang JW; Han JW; Lee SW; Bae SH; Choi JY; Han NI; Yoon SK; Kim HJ; Lee S; Cho SG; Min CK; Kim DW; Lee JW
Dig Dis Sci; 2019 Oct; 64(10):2992-3000. PubMed ID: 30982209
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort.
Hsu YC; Jun DW; Peng CY; Yeh ML; Trinh H; Wong GL; Kim SE; Chen CH; Oh H; Lin CH; Trinh L; Wong VW; Yoon E; Ahn SB; Huang D; Cho YK; Jeong JY; Jeong SW; Kim HS; Xie Q; Liu L; Riveiro-Barciela M; Tsai PC; Accarino EV; Toyoda H; Enomoto M; Preda C; Marciano S; Hoang J; Huang CF; Kozuka R; Yasuda S; Istratescu D; Lee DH; Su JY; Huang YT; Huang JF; Dai CY; Chuang WL; Yuen MF; Gadano A; Cheung R; Lim SG; Buti M; Yu ML; Nguyen MH
Hepatol Int; 2022 Dec; 16(6):1297-1307. PubMed ID: 36070123
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e-antigen seroclearance.
Fung J; Cheung KS; Wong DK; Mak LY; To WP; Seto WK; Lai CL; Yuen MF
Hepatology; 2018 Aug; 68(2):462-472. PubMed ID: 29534307
[TBL] [Abstract][Full Text] [Related]
36. Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis.
Yeo YH; Ho HJ; Yang HI; Tseng TC; Hosaka T; Trinh HN; Kwak MS; Park YM; Fung JYY; Buti M; Rodríguez M; Treeprasertsuk S; Preda CM; Ungtrakul T; Charatcharoenwitthaya P; Li X; Li J; Zhang J; Le MH; Wei B; Zou B; Le A; Jeong D; Chien N; Kam L; Lee CC; Riveiro-Barciela M; Istratescu D; Sriprayoon T; Chong Y; Tanwandee T; Kobayashi M; Suzuki F; Yuen MF; Lee HS; Kao JH; Lok AS; Wu CY; Nguyen MH
Gastroenterology; 2019 Feb; 156(3):635-646.e9. PubMed ID: 30342034
[TBL] [Abstract][Full Text] [Related]
37. Impact of HBsAg seroclearance on late recurrence of hepatitis B virus-related hepatocellular carcinoma after surgical resection.
Yoo S; Kim JY; Lim YS; Han S; Choi J
J Hepatol; 2022 Oct; 77(4):939-946. PubMed ID: 35643206
[TBL] [Abstract][Full Text] [Related]
38. Anti-HBc IgG Levels: A Predictor of HBsAg Seroclearance in Chronic Hepatitis B Patients with Nucleos(t)ide Analogue-Induced HBeAg Seroclearance.
Kim S; Yoo S; Lee JI; Kim S; Chang HY; Kim D; Jeong SH; Lee KS; Lee HW
Dig Dis Sci; 2022 Jan; 67(1):321-328. PubMed ID: 33517556
[TBL] [Abstract][Full Text] [Related]
39. Low Hepatitis B Core-Related Antigen Levels Correlate Higher Spontaneous Seroclearance of Hepatitis B Surface Antigen in Chronic Hepatitis B Patients With High Hepatitis B Surface Antigen Levels.
Tseng TC; Chiang C; Liu CJ; Hong CM; Su TH; Yang HC; Yang WT; Liu CH; Chen PJ; Kao JH
Gastroenterology; 2023 Apr; 164(4):669-679.e6. PubMed ID: 36642151
[TBL] [Abstract][Full Text] [Related]
40. Hepatitis B surface antigen seroclearance in patients with chronic hepatitis B infection: a clinical study.
Ruan P; Xu SY; Zhou BP; Huang J; Gong ZJ
J Int Med Res; 2013 Oct; 41(5):1732-9. PubMed ID: 23908397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
